PATRICIA CRAIG: Open Payments
NPI 1598847824 · LEXINGTON PARK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,995 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| PFIZER INC. | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Eisai Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: IBRANCE, PLUVICTO, IMFINZI, TAGRISSO, Lenvima, Epkinly, PROVENGE, Enhertu.
Industry payments across MD — which companies pay providers there.
